Capital Raising & Strategic Introductions for Biotech Companies
Cross-border access to institutional investors and pharmaceutical partners across the United States, Europe and Asia.
Fashioning the Future of Science
Nova Biotech Capital is an independent advisory focused on connecting biotechnology companies with institutional capital and strategic pharmaceutical partners.
Stronger together — building breakthroughs through trusted partnerships and shared innovation.
About Nova Biotech Capital
Nova Biotech Capital is an independent advisory specialized in capital raising and strategic introductions within the biotechnology sector.
We work with innovative biotech companies seeking institutional investment, pharmaceutical partnerships and cross-border opportunities.
Our approach is selective and execution-focused, connecting companies with the right investors and industry partners across the United States, Europe and Asia.
We maintain relationships with investors, pharmaceutical companies and industry participants that allow us to facilitate strategic introductions and funding opportunities for emerging and growing biotechnology companies.
Innovating the Future, One Discovery at a Time
Access to biotech investors, institutional funds and strategic capital for growth, expansion or acquisitions.
Direct introductions to pharmaceutical decision-makers and life sciences partners for licensing agreements, collaborations and strategic partnerships.
Advisory support for international biotech transactions and capital initiatives between the United States, Europe and Asia.
Start a Confidential Conversation
If you are a biotechnology company seeking capital or strategic partnerships, we invite you to connect with us for a confidential discussion. We are committed to understanding your vision and exploring opportunities to support your growth.
Why Nova Biotech Capital
Specialized Focus
Nova Biotech Capital works exclusively with biotechnology and life sciences companies, allowing for a deep understanding of the sector’s scientific, financial and strategic dynamics.
International Network
We maintain relationships with investors, pharmaceutical companies and industry partners across the United States, Europe and Asia.
Selective Engagement
We work with a limited number of companies to ensure dedicated attention and alignment throughout each engagement.
Strategic Access
Our role is to facilitate meaningful introductions between biotechnology innovators and the right investors or pharmaceutical partners.
Confidential Approach
All engagements are handled with strict confidentiality and professional discretion.
Start a Confidential Conversation
If you are a biotechnology company seeking capital or strategic partnerships, we invite you to connect with us for a confidential discussion. We are committed to understanding your vision and exploring opportunities to support your growth.
How We Support Growth
01
Initial Interest / Teaser & CDA (NDA):
Signing of the confidentiality agreement and sharing of the teaser or executive summary.
02
Data Room Review (Initial Due Diligence):
Access to the data room containing preclinical, clinical, CMC, IP, regulatory, and other relevant information. Risks and gaps are assessed and benchmarked.
03
Questions & Q&A Rounds:
Exchange of technical and financial questions. May include meetings with the scientific and management teams.
04
Internal Modeling & Preliminary Decision:
Development of valuation models, scenario analysis, and ROI projections. Decision on whether to proceed with a non- binding offer (term sheet).
05
Term Negotiation (LOI / Term Sheet):
Drafting and negotiation of key terms such as milestones, royalties, equity, and upfront payments.
06
Final Due Diligence & Definitive Agreement:
If proceeding, final legal, IP, CMC, and compliance review leading to deal closing.
Sector Focus
Nova Biotech Capital works exclusively with companies operating in the biotechnology and life sciences sectors.
We support organizations developing innovative technologies, therapeutic solutions and scientific platforms that require institutional capital and strategic partnerships.
Our focus includes companies seeking:
- Growth capital
- Strategic pharmaceutical partnerships
- Cross-border expansion opportunities
Start a Confidential Discussion
If you are a biotechnology company seeking capital or strategic partnerships, we invite you to connect with us for a confidential discussion. We are committed to understanding your vision and exploring opportunities to support your growth.
English
Spanish